The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostate Cancer Screening Market Research Report 2025
Synopsis
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.
The global Prostate Cancer Screening market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 22660 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Screening.
Report Scope
The Prostate Cancer Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Almac
Bayer
Beckman Coulter
BioméRieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics
Segment by Type
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
Segment by Application
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.
The global Prostate Cancer Screening market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 22660 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Screening.
Report Scope
The Prostate Cancer Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Almac
Bayer
Beckman Coulter
BioméRieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics
Segment by Type
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
Segment by Application
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Physical Exam
1.2.3 Laboratory Tests
1.2.4 Imaging Tests
1.2.5 Gleason Score
1.2.6 TNM Score
1.2.7 Genetic Tests
1.2.8 Digital Rectal Exam
1.2.9 Biopsy
1.3 Market by Application
1.3.1 Global Prostate Cancer Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.3.5 Cancer Institutes
1.3.6 Diagnostic Centers
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Screening Market Perspective (2019-2030)
2.2 Prostate Cancer Screening Growth Trends by Region
2.2.1 Global Prostate Cancer Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Cancer Screening Historic Market Size by Region (2019-2024)
2.2.3 Prostate Cancer Screening Forecasted Market Size by Region (2025-2030)
2.3 Prostate Cancer Screening Market Dynamics
2.3.1 Prostate Cancer Screening Industry Trends
2.3.2 Prostate Cancer Screening Market Drivers
2.3.3 Prostate Cancer Screening Market Challenges
2.3.4 Prostate Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Screening Players by Revenue
3.1.1 Global Top Prostate Cancer Screening Players by Revenue (2019-2024)
3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Screening Revenue
3.4 Global Prostate Cancer Screening Market Concentration Ratio
3.4.1 Global Prostate Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Screening Revenue in 2023
3.5 Prostate Cancer Screening Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Screening Product Solution and Service
3.7 Date of Enter into Prostate Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Screening Breakdown Data by Type
4.1 Global Prostate Cancer Screening Historic Market Size by Type (2019-2024)
4.2 Global Prostate Cancer Screening Forecasted Market Size by Type (2025-2030)
5 Prostate Cancer Screening Breakdown Data by Application
5.1 Global Prostate Cancer Screening Historic Market Size by Application (2019-2024)
5.2 Global Prostate Cancer Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Cancer Screening Market Size (2019-2030)
6.2 North America Prostate Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate Cancer Screening Market Size by Country (2019-2024)
6.4 North America Prostate Cancer Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Screening Market Size (2019-2030)
7.2 Europe Prostate Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate Cancer Screening Market Size by Country (2019-2024)
7.4 Europe Prostate Cancer Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Screening Market Size (2019-2030)
8.2 Asia-Pacific Prostate Cancer Screening Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate Cancer Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate Cancer Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Screening Market Size (2019-2030)
9.2 Latin America Prostate Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate Cancer Screening Market Size by Country (2019-2024)
9.4 Latin America Prostate Cancer Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Screening Market Size (2019-2030)
10.2 Middle East & Africa Prostate Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate Cancer Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate Cancer Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Prostate Cancer Screening Introduction
11.1.4 Abbott Laboratories Revenue in Prostate Cancer Screening Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Almac
11.2.1 Almac Company Detail
11.2.2 Almac Business Overview
11.2.3 Almac Prostate Cancer Screening Introduction
11.2.4 Almac Revenue in Prostate Cancer Screening Business (2019-2024)
11.2.5 Almac Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Prostate Cancer Screening Introduction
11.3.4 Bayer Revenue in Prostate Cancer Screening Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Screening Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Screening Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 BioméRieux
11.5.1 BioméRieux Company Detail
11.5.2 BioméRieux Business Overview
11.5.3 BioméRieux Prostate Cancer Screening Introduction
11.5.4 BioméRieux Revenue in Prostate Cancer Screening Business (2019-2024)
11.5.5 BioméRieux Recent Development
11.6 Genomic Health
11.6.1 Genomic Health Company Detail
11.6.2 Genomic Health Business Overview
11.6.3 Genomic Health Prostate Cancer Screening Introduction
11.6.4 Genomic Health Revenue in Prostate Cancer Screening Business (2019-2024)
11.6.5 Genomic Health Recent Development
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Detail
11.7.2 Mayo Clinic Business Overview
11.7.3 Mayo Clinic Prostate Cancer Screening Introduction
11.7.4 Mayo Clinic Revenue in Prostate Cancer Screening Business (2019-2024)
11.7.5 Mayo Clinic Recent Development
11.8 Mdxhealth
11.8.1 Mdxhealth Company Detail
11.8.2 Mdxhealth Business Overview
11.8.3 Mdxhealth Prostate Cancer Screening Introduction
11.8.4 Mdxhealth Revenue in Prostate Cancer Screening Business (2019-2024)
11.8.5 Mdxhealth Recent Development
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Company Detail
11.9.2 Roche Diagnostics Business Overview
11.9.3 Roche Diagnostics Prostate Cancer Screening Introduction
11.9.4 Roche Diagnostics Revenue in Prostate Cancer Screening Business (2019-2024)
11.9.5 Roche Diagnostics Recent Development
11.10 Rosetta Genomics
11.10.1 Rosetta Genomics Company Detail
11.10.2 Rosetta Genomics Business Overview
11.10.3 Rosetta Genomics Prostate Cancer Screening Introduction
11.10.4 Rosetta Genomics Revenue in Prostate Cancer Screening Business (2019-2024)
11.10.5 Rosetta Genomics Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Detail
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Prostate Cancer Screening Introduction
11.11.4 Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2019-2024)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Hologic
11.12.1 Hologic Company Detail
11.12.2 Hologic Business Overview
11.12.3 Hologic Prostate Cancer Screening Introduction
11.12.4 Hologic Revenue in Prostate Cancer Screening Business (2019-2024)
11.12.5 Hologic Recent Development
11.13 Myriad Genetics
11.13.1 Myriad Genetics Company Detail
11.13.2 Myriad Genetics Business Overview
11.13.3 Myriad Genetics Prostate Cancer Screening Introduction
11.13.4 Myriad Genetics Revenue in Prostate Cancer Screening Business (2019-2024)
11.13.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
